{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T05:33:34Z","timestamp":1778650414938,"version":"3.51.4"},"reference-count":55,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["NET-2016-02363853"],"award-info":[{"award-number":["NET-2016-02363853"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","valueinhealthjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.jval.2021.07.015","type":"journal-article","created":{"date-parts":[[2021,9,4]],"date-time":"2021-09-04T16:52:00Z","timestamp":1630774320000},"page":"185-193","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Cost-Effectiveness of Posthospital Management of Acute Coronary Syndrome: A Real-World Investigation From Italy"],"prefix":"10.1016","volume":"25","author":[{"given":"Federico","family":"Rea","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaella","family":"Ronco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nello","family":"Martini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aldo Pietro","family":"Maggioni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Corrao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.jval.2021.07.015_bib1","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1001\/jama.2014.14681","article-title":"Nonobstructive coronary artery disease and risk of myocardial infarction","volume":"312","author":"Maddox","year":"2014","journal-title":"JAMA"},{"issue":"21","key":"10.1016\/j.jval.2021.07.015_bib2","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1056\/NEJMra1216063","article-title":"Mechanisms of acute coronary syndromes and their implications for therapy","volume":"368","author":"Libby","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.jval.2021.07.015_bib3","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1001\/jama.2009.1178","article-title":"Reduction in acute myocardial infarction mortality in the United States: risk-standardized mortality rates from 1995-2006","volume":"302","author":"Krumholz","year":"2009","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.jval.2021.07.015_bib4","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/eurheartj\/ehi511","article-title":"Dynamics of cardiovascular and all-cause mortality in Western and Eastern Europe between 1970 and 2000","volume":"27","author":"Kesteloot","year":"2006","journal-title":"Eur Heart J"},{"issue":"8","key":"10.1016\/j.jval.2021.07.015_bib5","first-page":"651","article-title":"Recent time trends of myocardial infarction rates in northern Italy. Results from the MONICA and CAMUNI registries in Brianza: 1993-1994 versus 1997-1998 [in Italian]","volume":"4","author":"Ferrario","year":"2003","journal-title":"Ital Heart J Suppl"},{"issue":"3","key":"10.1016\/j.jval.2021.07.015_bib6","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1177\/2047487316679522","article-title":"Trends in long-term prognosis after acute coronary syndrome","volume":"24","author":"Piironen","year":"2017","journal-title":"Eur J Prev Cardiol"},{"issue":"12","key":"10.1016\/j.jval.2021.07.015_bib7","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1177\/2047487317708677","article-title":"Early, intensive statin treatment reduces \u2018hard\u2019 cardiovascular outcomes after acute coronary syndrome","volume":"24","author":"Schwartz","year":"2017","journal-title":"Eur J Prev Cardiol"},{"issue":"7200","key":"10.1016\/j.jval.2021.07.015_bib8","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1136\/bmj.318.7200.1730","article-title":"Beta blockade after myocardial infarction: systematic review and meta regression analysis","volume":"318","author":"Freemantle","year":"1999","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.jval.2021.07.015_bib9","first-page":"145","article-title":"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients [published correction appears in N Engl J Med. 2000;342(18):1376] [published correction appears in N Engl J Med. 2000;342(10):748]","volume":"342","author":"Yusuf","year":"2000","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.jval.2021.07.015_bib10","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1177\/2047487318814970","article-title":"Patterns of treatment with antiplatelet therapy after an acute coronary syndrome: data from a large database in a community setting","volume":"26","author":"Cimminiello","year":"2019","journal-title":"Eur J Prev Cardiol"},{"issue":"7","key":"10.1016\/j.jval.2021.07.015_bib11","first-page":"494","article-title":"Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation [published correction appears in N Engl J Med. 2001;345(23):1716] [published correction appears in N Engl J Med. 2001;345(20):1506]","volume":"345","author":"Yusuf","year":"2001","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.jval.2021.07.015_bib12","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jacc.2012.11.017","article-title":"Smoking cessation after acute myocardial infarction","volume":"61","author":"Benowitz","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.jval.2021.07.015_bib13","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jama.2013.284427","article-title":"2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8) [published correction appears in JAMA. 2014;311(17):1809]","volume":"311","author":"James","year":"2014","journal-title":"JAMA"},{"issue":"8A","key":"10.1016\/j.jval.2021.07.015_bib14","doi-asserted-by":"crossref","first-page":"11i","DOI":"10.1016\/S0002-9149(02)02631-0","article-title":"National Cholesterol Education Program (NCEP)-The National Cholesterol Guidelines in 2001, Adult Treatment Panel (ATP) III. Approach to lipoprotein management in 2001 National Cholesterol Guidelines","volume":"90","author":"Grundy","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jval.2021.07.015_bib15","unstructured":"Stone NJ, Robinson JG, Lichtenstein AH, et\u00a0al. 2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines [published correction appears in Circulation. 2014;129(25)(suppl 2):S46-S48] [published correction appears in Circulation. 2015;132(25):e396]. Circulation 2014;129(25)(suppl 2):S1-S45."},{"issue":"25","key":"10.1016\/j.jval.2021.07.015_bib16","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1161\/CIR.0000000000000133","volume":"130","author":"Amsterdam","year":"2014","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.jval.2021.07.015_bib17","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","volume":"39","author":"Ibanez","year":"2017","journal-title":"Eur Heart J"},{"issue":"8","key":"10.1016\/j.jval.2021.07.015_bib18","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.jacc.2016.06.005","article-title":"Assessing the impact of medication adherence on long-term cardiovascular outcomes","volume":"68","author":"Bansilal","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.jval.2021.07.015_bib19","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ahj.2013.09.014","article-title":"Untangling the relationship between medication adherence and post-myocardial infarction outcomes: medication adherence and clinical outcomes","volume":"167","author":"Choudhry","year":"2014","journal-title":"Am Heart J"},{"issue":"2","key":"10.1016\/j.jval.2021.07.015_bib20","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1001\/jama.297.2.177","article-title":"Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction","volume":"297","author":"Rasmussen","year":"2007","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.jval.2021.07.015_bib21","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.ahj.2010.03.009","article-title":"Suboptimal use of evidence-based medical therapy in patients with acute myocardial infarction from the Korea Acute Myocardial Infarction Registry: prescription rate, predictors, and prognostic value","volume":"159","author":"Lee","year":"2010","journal-title":"Am Heart J"},{"issue":"17","key":"10.1016\/j.jval.2021.07.015_bib22","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1001\/archinte.166.17.1842","article-title":"Impact of medication therapy discontinuation on mortality after myocardial infarction","volume":"166","author":"Ho","year":"2006","journal-title":"Arch Intern Med"},{"issue":"4","key":"10.1016\/j.jval.2021.07.015_bib23","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1053\/j.semss.2009.08.003","article-title":"Decision analysis and cost-effectiveness analysis","volume":"21","author":"Ryder","year":"2009","journal-title":"Semin Spine Surg"},{"issue":"8","key":"10.1016\/j.jval.2021.07.015_bib24","article-title":"Acute and 1-year hospitalization costs for acute myocardial infarction treated with percutaneous coronary intervention: results from the TRANSLATE-ACS registry","volume":"8","author":"Cowper","year":"2019","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"1","key":"10.1016\/j.jval.2021.07.015_bib25","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1472-6963-11-35","article-title":"Economic burden of illness of acute coronary syndromes: medical and productivity costs","volume":"11","author":"Zhao","year":"2011","journal-title":"BMC Health Serv Res"},{"issue":"4","key":"10.1016\/j.jval.2021.07.015_bib26","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1177\/2047487320942644","article-title":"A\u00a0cost-utility analysis of increasing percutaneous coronary intervention use in elderly patients with acute coronary syndromes in 6 European countries","volume":"28","author":"Forn\u00e9","year":"2021","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.jval.2021.07.015_bib27","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ijcard.2020.06.017","article-title":"Better adherence with out-of-hospital healthcare improved long-term prognosis of acute coronary syndromes: evidence from an Italian real-world investigation","volume":"318","author":"Rea","year":"2020","journal-title":"Int J Cardiol"},{"issue":"2","key":"10.1016\/j.jval.2021.07.015_bib28","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1161\/HYPERTENSIONAHA.120.14683","article-title":"Antihypertensive treatment in elderly frail patients: evidence from a large Italian database","volume":"76","author":"Rea","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.jval.2021.07.015_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2020.108197","article-title":"Balancing cardiovascular benefit and diabetogenic harm of therapy with statins: real-world evidence from Italy","volume":"164","author":"Corrao","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"issue":"3","key":"10.1016\/j.jval.2021.07.015_bib30","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s40264-018-0732-5","article-title":"The role of European healthcare databases for post-marketing drug effectiveness, safety and value evaluation: where does Italy stand?","volume":"42","author":"Trifir\u00f2","year":"2019","journal-title":"Drug Saf"},{"issue":"12","key":"10.1016\/j.jval.2021.07.015_bib31","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-019503","article-title":"Developing and validating a novel multisource comorbidity score from administrative data: a large population-based cohort study from Italy","volume":"7","author":"Corrao","year":"2017","journal-title":"BMJ Open"},{"issue":"3","key":"10.1016\/j.jval.2021.07.015_bib32","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.ahj.2010.06.023","article-title":"beta-Blocker use following myocardial infarction: low prevalence of evidence-based dosing","volume":"160","author":"Goldberger","year":"2010","journal-title":"Am Heart J"},{"issue":"8","key":"10.1016\/j.jval.2021.07.015_bib33","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/pds.1230","article-title":"Methods for evaluation of medical adherence and persistence using automated databases","volume":"15","author":"Andrade","year":"2006","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"4","key":"10.1016\/j.jval.2021.07.015_bib34","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/EDE.0b013e3181a663cc","article-title":"High-dimensional propensity score adjustment in studies of treatment effects using health care claims data [published correction appears in Epidemiology. 2018;29(6):e63-e64]","volume":"20","author":"Schneeweiss","year":"2009","journal-title":"Epidemiology"},{"issue":"6","key":"10.1016\/j.jval.2021.07.015_bib35","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1002\/sim.6004","article-title":"A\u00a0comparison of 12 algorithms for matching on the propensity score","volume":"33","author":"Austin","year":"2014","journal-title":"Stat Med"},{"issue":"446","key":"10.1016\/j.jval.2021.07.015_bib36","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A\u00a0Proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J\u00a0Am Stat Assoc"},{"issue":"12","key":"10.1016\/j.jval.2021.07.015_bib37","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1001\/jamaoncol.2017.2797","article-title":"Interpretability of cancer clinical trial results using restricted mean survival time as an alternative to the hazard ratio","volume":"3","author":"Pak","year":"2017","journal-title":"JAMA Oncol"},{"issue":"2","key":"10.1016\/j.jval.2021.07.015_bib38","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/biomet\/87.2.329","article-title":"Estimating medical costs with censored data","volume":"87","author":"Bang","year":"2000","journal-title":"Biometrika"},{"issue":"25","key":"10.1016\/j.jval.2021.07.015_bib39","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1016\/j.jacc.2008.09.018","article-title":"Interpreting the results of cost-effectiveness studies","volume":"52","author":"Cohen","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jval.2021.07.015_bib40","series-title":"Methods for the Economic Evaluation of Health Care Programmes","author":"Drummond","year":"2015"},{"issue":"3","key":"10.1016\/j.jval.2021.07.015_bib41","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s40273-018-0755-x","article-title":"Evaluating cost-effectiveness models for pharmacologic interventions in adults with heart failure: a systematic literature review","volume":"37","author":"Di Tanna","year":"2019","journal-title":"Pharmacoeconomics"},{"issue":"2","key":"10.1016\/j.jval.2021.07.015_bib43","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.amjcard.2011.08.024","article-title":"Effect of use of combination evidence-based medical therapy after acute coronary syndromes on long-term outcomes","volume":"109","author":"Lahoud","year":"2012","journal-title":"Am J Cardiol"},{"issue":"19","key":"10.1016\/j.jval.2021.07.015_bib44","doi-asserted-by":"crossref","first-page":"e215","DOI":"10.1016\/j.jacc.2011.02.011","volume":"57","author":"Wright","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.jval.2021.07.015_bib45","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1177\/2047487315597209","article-title":"Determinants of adherence to evidence-based therapy after acute myocardial infarction","volume":"23","author":"Hamood","year":"2016","journal-title":"Eur J Prev Cardiol"},{"issue":"2","key":"10.1016\/j.jval.2021.07.015_bib46","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1001\/jamacardio.2016.0001","article-title":"Timing of first postdischarge follow-up and medication adherence after acute myocardial infarction","volume":"1","author":"Faridi","year":"2016","journal-title":"JAMA Cardiol"},{"issue":"13","key":"10.1016\/j.jval.2021.07.015_bib47","article-title":"Clinical effectiveness of cardiac noninvasive diagnostic testing in outpatients evaluated for stable coronary artery disease","volume":"9","author":"Roifman","year":"2020","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"16","key":"10.1016\/j.jval.2021.07.015_bib48","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1177\/2047487320905719","article-title":"Effectiveness of comprehensive cardiac rehabilitation in coronary artery disease patients treated according to contemporary evidence based medicine: update of the Cardiac Rehabilitation Outcome Study (CROS-II)","volume":"27","author":"Salzwedel","year":"2020","journal-title":"Eur J Prev Cardiol"},{"issue":"1","key":"10.1016\/j.jval.2021.07.015_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2015.10.044","article-title":"Exercise-based cardiac rehabilitation for coronary heart disease: Cochrane systematic review and meta-analysis","volume":"67","author":"Anderson","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"29","key":"10.1016\/j.jval.2021.07.015_bib50","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1093\/eurheartj\/ehw106","volume":"37","author":"Piepoli","year":"2016","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.jval.2021.07.015_bib51","doi-asserted-by":"crossref","first-page":"e362","DOI":"10.1161\/CIR.0b013e3182742c84","volume":"127","author":"O\u2019Gara","year":"2013","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.jval.2021.07.015_bib52","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.11686","article-title":"Association of cardiac rehabilitation with all-cause mortality among patients with cardiovascular disease in The Netherlands","volume":"3","author":"Eijsvogels","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"3","key":"10.1016\/j.jval.2021.07.015_bib53","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s40471-016-0085-5","article-title":"Population attributable and preventable fractions: cancer risk factor surveillance, and cancer policy projection","volume":"3","author":"Shield","year":"2016","journal-title":"Curr Epidemiol Rep"},{"issue":"5","key":"10.1016\/j.jval.2021.07.015_bib54","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1177\/2047487312449591","article-title":"Use and effects of cardiac rehabilitation in patients with coronary heart disease: results from the EUROASPIRE III survey","volume":"20","author":"Kotseva","year":"2013","journal-title":"Eur J Prev Cardiol"},{"issue":"5","key":"10.1016\/j.jval.2021.07.015_bib55","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1524-4733.2007.00186.x","article-title":"Using real-world data for coverage and payment decisions: the ISPOR Real-world Data Task Force report","volume":"10","author":"Garrison","year":"2007","journal-title":"Value Health"},{"issue":"17","key":"10.1016\/j.jval.2021.07.015_bib56","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1001\/archinternmed.2009.324","article-title":"The healthy adherer effect","volume":"169","author":"Andersohn","year":"2009","journal-title":"Arch Intern Med"}],"container-title":["Value in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301521016843?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301521016843?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T01:25:29Z","timestamp":1761096329000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098301521016843"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":55,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S1098301521016843"],"URL":"https:\/\/doi.org\/10.1016\/j.jval.2021.07.015","relation":{},"ISSN":["1098-3015"],"issn-type":[{"value":"1098-3015","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost-Effectiveness of Posthospital Management of Acute Coronary Syndrome: A Real-World Investigation From Italy","name":"articletitle","label":"Article Title"},{"value":"Value in Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jval.2021.07.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 International Society for Pharmacoeconomics and Outcomes Research, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}